Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance

Journal of Oral Pathology and Medicine

Volumn 37, Issue 10, 2008, Pages 616-625

  Zhao, D ^a,b   Pan, J ^b   Li, Xq ^a   Wang, Xy ^a,b   Tang, C ^b   Xuan, M ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

D2 40; Lymphangiogenesis; Lymphatic metastasis; Oral squamous cell carcinoma; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY D2-40;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL BIOPSY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KERATINS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 53549115923     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00707.x     Document Type: Article

References (37)

1. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999 144 : 789 801.
2. Breiteneder-Geleff S, Soleiman A, Kowalski H et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999 154 : 385 94.
3. Wigle JT, Oliver G. Proxl function is required for the development of the murine lymphatic system. Cell 1999 98 : 769 78.
4. Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995 92 : 3566 70.
5. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002 82 : 1255 7.
6. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004 25 : 387 95.
7. Padera TP, Kadambi A, di Tomaso E et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002 296 : 1883 6. [E-pub 25 April 2002].
8. Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: what do we know? Microsc Res Techn 2003 60 : 171 80.
9. Jain RK, Fenton BT. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 2002 94 : 417 21.
10. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002 2 : 573 83.
11. Clarijs R, Ruiter DJ, de Waal RM. Lymphangiogenesis in malignant tumours: does it ccur? J Pathol 2001 193 : 143 6.
12. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001 7 : 462 8.
13. Williams CS, Leek RD, Robson AM et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 2003 200 : 195 206.
14. Beasley NJ, Prevo R, Banerji S et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002 62 : 1315 20.
15. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001 7 : 151 2.
16. Mandriota SJ, Jussila L, Jeltsch M et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001 20 : 672 82.
17. Stacker SA, Caesar C, Baldwin ME et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001 7 : 186 91.
18. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002 1 : 219 27.
19. Vleugel MM, Bos R, van der Groep P et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 2004 57 : 746 51.
20. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003 9 : 250 56.
21. Niakosari F, Kahn HJ, Marks A, From L. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol 2005 141 : 440 4.
22. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003 63 : 1920 6.
23. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 2004 101 : 973 8.
24. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence of lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005 206 : 170 7.
25. Omachi T, Kawai Y, Mizuno R et al. Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett 2006 246 : 167 72.
26. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Modern Pathol 2006 19 : 1317 23.
27. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991 324 : 1 8.
28. Schoppmann SF, Bayer G, Aumayr K et al. Austrian Breast and Colorectal Cancer Study Group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004 240 : 306 12.
29. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994 86 : 829 35.
30. Pettersson A, Nagy JA, Brown LF et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Investig 2000 80 : 99 115.
31. Witte MH, Witte CL. Lymphangiogenesis and lymphologic syndromes. Lymphology 1986 19 : 21 8.
32. Dadras SS, Paul T, Bertoncini J et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003 162 : 1951 60.
33. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 2001 21 : 2351 5.
34. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 2001 95 : 29 33.
35. Schoppmann SF, Birner P, Stockl J et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002 161 : 947 56.
36. Munoz-Guerra MF, Marazuela EG, Martin-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer 2004 100 : 553 60.
37. Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node Metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007 110 : 1287 94.